Skip to content
10-Q

Quarterly Report

CASI PHARMACEUTICALS, INC.

0001558370-22-013418

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 5, 2022 13.61M sh
Shares Diluted Q2 2022 · Jun 30, 2022 13.61M sh
Shares Diluted Q2 2022 · Jun 30, 2022 13.7M sh
Shares Diluted restated Q2 2022 · Jun 30, 2021 13.98M sh
Shares Diluted restated Q2 2022 · Jun 30, 2021 13.24M sh
Stock Repurchased Q2 2022 · Jun 30, 2022 $3M
Capex Q2 2022 · Jun 30, 2022 $1.72M
Capex Q2 2022 · Jun 30, 2021 $1.21M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$13.72M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$15.34M
Short Term Debt Q2 2022 · Jun 30, 2022 $1M
Short Term Investments Q2 2022 · Jun 30, 2022 $5.71M
Short Term Investments Q2 2022 · Dec 31, 2021 $9.87M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $18.86M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $38.7M
Stockholders Equity Q2 2022 · Jun 30, 2022 $66.94M
Stockholders Equity Q2 2022 · Mar 31, 2022 $74.99M
Stockholders Equity Q2 2022 · Dec 31, 2021 $84.5M
Stockholders Equity Q2 2022 · Jun 30, 2021 $94.8M
Stockholders Equity Q2 2022 · Mar 31, 2021 $100.03M
Stockholders Equity Q2 2022 · Dec 31, 2020 $81.54M
Current Liabilities Q2 2022 · Jun 30, 2022 $13.18M
Current Liabilities Q2 2022 · Dec 31, 2021 $13.19M
Total Liabilities Q2 2022 · Jun 30, 2022 $29.25M
Total Liabilities Q2 2022 · Dec 31, 2021 $30.34M
Current Assets Q2 2022 · Jun 30, 2022 $42.28M
Current Assets Q2 2022 · Dec 31, 2021 $61.97M
Total Assets Q2 2022 · Jun 30, 2022 $118.86M
Total Assets Q2 2022 · Dec 31, 2021 $138.3M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.56
Eps Diluted Q2 2022 · Jun 30, 2022 −$1.19
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.50
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.57
Eps Basic Q2 2022 · Jun 30, 2022 −$0.56
Eps Basic Q2 2022 · Jun 30, 2022 −$1.19
Eps Basic Q2 2022 · Jun 30, 2021 −$0.50
Eps Basic Q2 2022 · Jun 30, 2021 −$1.57
Sga Expense Q2 2022 · Jun 30, 2022 $5.52M
Sga Expense Q2 2022 · Jun 30, 2022 $10.85M
Sga Expense restated Q2 2022 · Jun 30, 2021 $5.49M
Sga Expense restated Q2 2022 · Jun 30, 2021 $10.99M
Net Income Q2 2022 · Jun 30, 2022 −$7.68M
Net Income Q2 2022 · Jun 30, 2022 −$16.28M
Net Income Q2 2022 · Mar 31, 2022 −$8.6M
Net Income Q2 2022 · Jun 30, 2021 −$6.95M
Net Income Q2 2022 · Jun 30, 2021 −$20.83M
Net Income Q2 2022 · Mar 31, 2021 −$13.88M
Operating Income Q2 2022 · Jun 30, 2022 −$7.75M
Operating Income Q2 2022 · Jun 30, 2022 −$15.04M
Operating Income Q2 2022 · Jun 30, 2021 −$7.98M
Operating Income Q2 2022 · Jun 30, 2021 −$23.58M
Gross Profit Q2 2022 · Jun 30, 2022 $5.02M
Gross Profit Q2 2022 · Jun 30, 2022 $10.33M
Gross Profit Q2 2022 · Jun 30, 2021 $4.18M
Gross Profit Q2 2022 · Jun 30, 2021 $7.56M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $3.55M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $7.31M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $2.98M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $5.34M
Revenue Q2 2022 · Jun 30, 2022 $8.55M
Revenue Q2 2022 · Jun 30, 2022 $17.58M
Revenue Q2 2022 · Jun 30, 2021 $7.13M
Revenue Q2 2022 · Jun 30, 2021 $12.83M
Stock Issued Q2 2022 · Mar 31, 2022 2.54M sh
Stock Issued Q2 2022 · Mar 24, 2021 15.85M sh